Novel Dried Blood Spot Protocol Shows Promise for Hepatitis C Treatment Initiation in Peer-Assisted Telemedicine

References

1. 1.Bajis, S., Dore, G. J., Hajarizadeh, B., Cunningham, E. B., Maher, L., & Grebely, J. (2017). Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: a systematic review. International Journal of Drug Policy, 47, 99-110. https://doi.org/10.1016/j.drugpo.2017.07.002
2. 2.Chappell, C. A., Hillier, S. L., Crowe, D., Meyn, L. A., Bogen, D. L., & Krans, E. E. (2020). Hepatitis C virus screening among children exposed during pregnancy. Pediatrics, 145(2), e20192482. https://doi.org/10.1542/peds.2019-2482
3. 3.Cunningham, E. B., Hajarizadeh, B., Amin, J., Litwin, A. H., Gane, E., Cooper, C., ... & Grebely, J. (2018). Adherence to once-daily sofosbuvir/velpatasvir in people with hepatitis C virus infection and recent injection drug use: the SIMPLIFY study. Journal of Viral Hepatitis, 25(11), 1384-1393. https://doi.org/10.1111/jvh.12987
4. 4.Dore, G. J., Altice, F., Litwin, A. H., Dalgard, O., Gane, E. J., Shibolet, O., ... & Grebely, J. (2016). Elbasvir–grazoprevir to treat hepatitis C virus infection in persons receiving opioid agonist therapy: a randomized trial. Annals of Internal Medicine, 165(9), 625-634. https://doi.org/10.7326/M16-0816
5. 5.Grebely, J., Dalgard, O., Conway, B., Cunningham, E. B., Bruggmann, P., Hajarizadeh, B., ... & Dore, G. J. (2018). Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial. The Lancet Gastroenterology & Hepatology, 3(3), 153-161. https://doi.org/10.1016/S2468-1253(18)30207-9
6. 6.Hajarizadeh, B., Grebely, J., & Dore, G. J. (2013). Epidemiology and natural history of HCV infection. Nature Reviews Gastroenterology & Hepatology, 10(9), 553-562. https://doi.org/10.1038/nrgastro.2013.107
7. 7.Norton, B. L., Fleming, J., Bachhuber, M. A., Steinman, M., DeLuca, J., Cunningham, C. O., & Litwin, A. H. (2017). High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic. International Journal of Drug Policy, 47, 196-201. https://doi.org/10.1016/j.drugpo.2017.05.021
8. 8.Oregon Health and Science University. (2024). Dried Blood Spot Testing in Peer-assisted Telemedicine for Hepatitis C Treatment. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT06409169
9. 9.World Health Organization. (2022). Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030. World Health Organization. https://www.who.int/publications/i/item/9789240053779
10. 10.World Health Organization. (2023). Global hepatitis report 2024: action for access in low- and middle-income countries. World Health Organization. https://www.who.int/publications/i/item/9789240091672